Unknown

Dataset Information

Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.


ABSTRACT:

Background

Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis (DR-TB) are likely to bring about substantial transformations in TB treatment in coming years. An evidence base for cost and cost-effectiveness analyses of these developments is needed.

Objective

Our objective was to perform a review of papers assessing provider-incurred as well as patient-incurred costs of treating both drug-susceptible (DS) and multidrug-resistant (MDR)-TB.

Methods

Five databases (EMBASE, Medline, the National Health Service Economic Evaluation Database, the Cost-Effectiveness Analysis Registry, and Latin American and Caribbean Health Services Literature) were searched for cost and economic evaluation full-text papers containing primary DS-TB and MDR-TB treatm

SUBMITTER: Laurence YV 

PROVIDER: S-EPMC4559093 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature